Jacob Bell
New Member
Patent References
3668224
3728360
3734930
3799946
3920809
Abstract
Significant success in alleviating the symptoms of glaucoma is achieved by orally administering to a glaucoma sufferer a therapeutically effective, but sub-psychotropic dose of tetrahydrocannabinol (THC), which is the most active ingredient in marijuana. The most significant results are achieved when this form of treatment is combined with conventional types of anti-glaucoma treatment, although in a limited number of cases, THC therapy alone proved successful. Also disclosed is a dosage unit form for THC comprising a suitable dose of THC in combination with an innocuous diluent such as fructose.
Other References
The Merck Index, 8th ed. pp. 830, 831 and 833 (1968) Merck & Co
Ophthalmologica 168 366-369 (1974)--D. Shapiro--The Ocular Manifestations of the Cannabinols, Newsweek, 11/8/76, Pot and Glaucoma
Chem. Abst. 83 158,044(r) (1975)--Purnell et al. "A9 -Tetrahydrocannabinol . . . in Man"
Chem. Abst. 84 130,270(h) (1976)--Green et al. Interaction of . . . Tetrahydrocannabinol in the Eye"
Source: Tetrahydrocannabinol in a method of treating glaucoma - US Patent 4189491
3668224
3728360
3734930
3799946
3920809
Abstract
Significant success in alleviating the symptoms of glaucoma is achieved by orally administering to a glaucoma sufferer a therapeutically effective, but sub-psychotropic dose of tetrahydrocannabinol (THC), which is the most active ingredient in marijuana. The most significant results are achieved when this form of treatment is combined with conventional types of anti-glaucoma treatment, although in a limited number of cases, THC therapy alone proved successful. Also disclosed is a dosage unit form for THC comprising a suitable dose of THC in combination with an innocuous diluent such as fructose.
Other References
The Merck Index, 8th ed. pp. 830, 831 and 833 (1968) Merck & Co
Ophthalmologica 168 366-369 (1974)--D. Shapiro--The Ocular Manifestations of the Cannabinols, Newsweek, 11/8/76, Pot and Glaucoma
Chem. Abst. 83 158,044(r) (1975)--Purnell et al. "A9 -Tetrahydrocannabinol . . . in Man"
Chem. Abst. 84 130,270(h) (1976)--Green et al. Interaction of . . . Tetrahydrocannabinol in the Eye"
Source: Tetrahydrocannabinol in a method of treating glaucoma - US Patent 4189491
